相关实验视频
Updated: Jul 13, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
药物 (衍生物) 分子的晚期C-H激活与Pd (ll) 催化
1Infectious Diseases Therapeutic Research Center Division of Medicinal Chemistry and Pharmacology Korea Research Institute of Chemical Technology (KRICT) KRICT School, University of Science and Technology, Daejeon, 34114, Republic of Korea.
Chemistry (Weinheim an der Bergstrasse, Germany)
|October 17, 2023
概括
((II) 催化后期C-H激活有效地改变药物分子. 本综述强调了选择性功能化的方法,推动了药物发现和开发.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 催化剂是一种催化剂.
背景情况:
- 晚期功能化对于药物发现至关重要.
- ((II) 催化剂被广泛用于C-H激活.
- 现有的审查缺乏对药物衍生品中Pd(II) 催化后期C-H激活的关注.
研究的目的:
- 在药物 (衍生物) 分子中全面审查Pd(II) 催化后期C-H激活反应.
- 为了证明这些反应在将C-H键转化为多种功能组的有效性.
- 突出这些方法在药物化学中的潜力.
主要方法:
- 对Pd(II) 催化后期C-H激活反应的代表性示例进行分析.
- 专注于涉及药物 (衍生物) 分子的反应.
- 引入的功能组的分类和区域选择性和功能组耐受性的评估.
主要成果:
- Pd(II) 催化使药物分子中多个位置的有效和选择性C-H键功能化成为可能.
- 可以引入不同的功能组 (例如,CN,F,Cl,芳香环,烯,基,基,基,基).
- 实现了高的区域选择性和功能组耐受性.
结论:
- Pd (II) 催化后期C-H激活是药物发现和开发的强大工具.
- 这些方法为优化候选药物提供了战略选择.
- 该审查强调了通过有针对性的分子修饰探索创新治疗解决方案的潜力.
相关概念视频
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.3K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.3K
Drug Metabolism: Phase I Reactions
3.3K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.3K
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Phase II Reactions: Methylation Reactions
205
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
205
Catalysis
27.0K
The presence of a catalyst affects the rate of a chemical reaction. A catalyst is a substance that can increase the reaction rate without being consumed during the process. A basic comprehension of a catalysts’ role during chemical reactions can be understood from the concept of reaction mechanisms and energy diagrams.
27.0K
Reduction of Alkynes to cis-Alkenes: Catalytic Hydrogenation
7.8K
Introduction
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
7.8K

